Association of Oncotype-DX HER2 Single Gene Score With HER2 Expression Assessed by Immunohistochemistry in HER2-low Breast Cancer
Oncotype-DX single-gene scores for HER2 are a potential surrogate marker for assessing the precise HER2 status, with better reproducibility and less interobserver variance compared to immunohistochemistry. The use of rt-PCR emerges as an alternative method of assessment of the HER2-low subgroup.
Authors
- Loukas Kontovinis
- Ioannis Natsiopoulos
- George Douganiotis
- Konstantinos Papazisis (ORCID: https://orcid.org/0000-0002-1048-2715)
- Thomas Zarampoukas
Institutions
- OncoMed (United States) (US)
- Interbalkan Medical Center (GR)
- Euromedica (GR)
- Hellenic Agency for Local Development and Local Government (GR)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21873/cdp.10370
- Citations
- 3
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85